Ada
Ada
ADA
Adenosine Inosine
PNP
Inosine Hypoxanthine
XOD
Hypoxanthine Uric Acid+H2O2
POD
H2O2 +EHSPT+4-AAP Benzoquinone
This Benzoquinone is detected as an absorbance change (546 nm), with the
increase of the absorbency being proportional to the quantity of ADA in the
sample.
English 1-1 P/N: 046-003476-00(5.0)
ADA
Reagents
Components and activity
Tris-HCl 50 mmol/L
4-AAP 2 mmol/L
R1 PNP 0.1 U/mL
XOD 0.2 U/mL
Peroxidase 0.6 U/mL
Tris-HCl 50 mmol/L
R2 Adenosine 10 mmol/L
EHSPT 2 mmol/L
Warnings and precautions
1.For in vitro diagnostic use only.
2.Take the necessary precautions for the use of laboratory reagents.
3.Preservative contained. Do not swallow. Avoid contact with skin and
mucous membranes.
4.Disposal of all waste material should be in accordance with local
guidelines.
5.Material safety data sheet is available for professional user on request.
Reagent Preparation
R1 and R2 are ready to use.
Storage and stability
Up to expiration date indicated on the label, when stored unopened at 2-8℃
and protected from light.
Once opened, the reagents are stable for 14 days when refrigerated on the
analyzer or refrigerator.
Contamination of the reagents must be avoided.
Do not freeze the reagents.
Reagent blank absorbency
The absorbance of reagent blank at 546 nm should be <0.1 A.
Materials required but not provided
1.NaCl solution 9 g/L
2.General laboratory equipments.
Specimen collection and preparation 2
1.Serum is suitable for samples. Whole blood and hemolysis are not
recommended for use as a sample. Freshly drawn serum is the preferred
specimen.
2.Use the suitable tubes or collection containers and follow the instruction of
the manufacturer; avoid effect of the materials of the tubes or other
collection containers.
3.Centrifuge samples containing precipitate before performing the assay.
English 1-2 P/N: 046-003476-00(5.0)
ADA
Assay procedure
Blank Sample
Reagent 1 180 μL 180 μL
Dist. water 5 μL -
Sample - 5 μL
Mix, incubate for 30s at 37 ℃, and read the blank absorbance, then add:
Reagent 2 90 μL 90μL
Mix thoroughly at 37 ℃, and read the absorbance again 2.5 min. later.
ΔA = [ΔA sample]- [ΔA blank]
Application sheets for BS series analyzers are available in this document.
Please refer to the appropriate operation manual for the analyzer-specific
assay instructions.
Calibration
1.It is recommended to use the Mindray calibrator and 9 g/L NaCl for
calibration. The calibrator is traceable to manufacturer’s selected
measurement.
2.Calibration frequency:
After reagent lot changed.
As required following quality control procedures.
Quality control
We recommend using Control made by Mindray to verify the performance of
the measurement procedure; other suitable control material can be used in
addition.
Each laboratory should establish its own internal quality control scheme and
procedures for corrective action if controls do not recover within the
acceptable tolerances.
Calculation
The analyzer calculates the ADA activity of each sample automatically after
calibration.
C sample = (ΔA sample/ΔA calibration)×C calibration
Reference Intervals 3
Each laboratory should establish its own reference intervals based upon its
patient population. The reference intervals measured at 37℃ listed below
were taken from literature:
Sample Type S.I. Units
Serum 4-24 U/L
Performance Characteristics
Representative performance data obtained from Mindray system (Mindray BS
series analyzers / Mindray ADA is given below. Results may vary if a different
instrument, an individual laboratory or a manual procedure is used.
English 1-3 P/N: 046-003476-00(5.0)
ADA
Limitations-interference
The following substances were tested for interference with this methodology.
Criterion: Recovery within ±10 % of initial value.
Substance Level Tested Observed Effect
Ascorbic acid 4mg/dL NSI*
Bilirubin 5mg/dL NSI
Hemoglobin 500 mg/dL NSI
Lipemia 500 mg/dl NSI
* NSI: No Significant Interference (within ± 10 %)
Linearity range
The Mindray System provides the following linearity range:
Sample Type S.I. Units
Serum 1-200 U/L
If the value of sample exceeds 200 U/L, the sample should be diluted with 9
g/L NaCl solution (e.g. 1+ 1) and rerun; the result should be multiplied by 2.
Analytic Sensitivity/Limit of Detection
The lowest measurable ADA activity that can be distinguished from zero is 1
U/L with 99.7% confidence.
Precision
Precision performance using the CLSI Approved Guideline EP5-A2 to assay
serum control appears in the table below. U: U/L
Level
Type of Imprecision
Mean SD CV %
Within-run 0.23 0.51
Between-run 0.00 0.00
45.32
Between-day 1.15 2.54
Within-device 0.85 1.87
Method Comparison
A comparison between Mindray System (Mindray BS series analyzers
/Mindray ADA Reagent) (y) and Hitachi/ruiyuan System (Hitachi /ruiyuan)
(x) using 40 samples gave following correlation (U/L): y = 0.9814x +
0.7442, R2 = 0.9994
Details of the comparison experiments are available on request.
References
1.Kobayashi F,Ikeda T,Marumo F,Sato C:Ad-enosine deaminase isoenzymes
in liver disease. Am. J. Gastroenterol. 88:266-271(1993)
2.KALLKAN a.,Bult V.,Erel O.,Avci S.,and Bingol N.K.:Adenosine deaminase
and gu-anosine deaminase activities in sera of patients with viral
hepatitis.Mem Inst.Oswaldo Cru 94(3)383-386(1999)